Protein phosphatase-2A (PP2A), a major regulator of tau phosphorylation [9, 10], is obviously decreased in the AD brains compared to normal [11, 12], while the level of its inhibitor 2 (I2PP2A), also known as SET, is increased [13, 14]. The gene discussed is MAPT; the disease is Alzheimer disease.